Laddar...
Therapies for mobility disability in persons with multiple sclerosis
INTRODUCTION: Mobility disability is one of the most widespread and impactful consequences of multiple sclerosis (MS). Disease modifying drugs (DMDs) may delay the progression of disability over time; however, there is minimal evidence supporting the efficacy of DMDs for reversing mobility disabilit...
Sparad:
| I publikationen: | Expert Rev Neurother |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6291756/ https://ncbi.nlm.nih.gov/pubmed/29772185 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14737175.2018.1478289 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|